• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Another quadruplet therapy for multiple myeloma: the beginning of the end for autologous haematopoietic stem-cell transplantation?

by | Apr 28, 2024 | Publications

Lancet Haematol. 2024 Apr 24:S2352-3026(24)00097-8. doi: 10.1016/S2352-3026(24)00097-8. Online ahead of print. NO ABSTRACT PMID:38677301 | DOI:10.1016/S2352-3026(24)00097-8

Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial

by | Apr 28, 2024 | Publications

Lancet Haematol. 2024 Apr 24:S2352-3026(24)00070-X. doi: 10.1016/S2352-3026(24)00070-X. Online ahead of print. ABSTRACT BACKGROUND: Isatuximab is a CD38 monoclonal antibody approved for relapsed or refractory multiple myeloma. We aimed to evaluate the addition of...

Biological Age is No Barrier for Adult Patients Undergoing CAR T for Non-Hodgkin’s Lymphoma or Multiple Myeloma

by | Apr 28, 2024 | Publications

Transplant Cell Ther. 2024 May;30(5):462-464. doi: 10.1016/j.jtct.2024.04.002. NO ABSTRACT PMID:38677789 | DOI:10.1016/j.jtct.2024.04.002

Diagnostic value of LGE and T1 mapping in multiple myeloma patients’heart

by | Apr 28, 2024 | Publications

BMC Cardiovasc Disord. 2024 Apr 27;24(1):230. doi: 10.1186/s12872-024-03895-y. ABSTRACT BACKGROUND: Unidentified heart failure occurs in patients with multiple myeloma when their heart was involved. CMR with late gadolinium enhancement (LGE) and T1 mapping can...

Small intestinal angiodysplasia and hemorrhage associated with acquired von Willebrand syndrome type 2A secondary to multiple myeloma: Reversal after treatment with IRD regimen (a case report and a brief review of the literature)

by | Apr 26, 2024 | Publications

Thromb Res. 2024 Apr 12;238:37-40. doi: 10.1016/j.thromres.2024.04.008. Online ahead of print. NO ABSTRACT PMID:38663044 | DOI:10.1016/j.thromres.2024.04.008

Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5

by | Apr 26, 2024 | Publications

Leuk Res. 2024 Feb 1;141:107451. doi: 10.1016/j.leukres.2024.107451. Online ahead of print. ABSTRACT BACKGROUND: Circular RNAs (circRNAs) are associated with development and progression of multiple myeloma (MM). However, the role and mechanism of circ_0005615 in MM...
« Older Entries
Next Entries »

Recent Content

  • Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
  • (no title)
  • Efficacy and toxicity of treatment of smoldering multiple myeloma: a systematic review and meta-analysis
  • (no title)
  • Peroxiredoxins as novel indicators in multiple myeloma associated with ferroptosis and immune infiltration
  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT